DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas
Related Experiment Videos
Martha J Felini1, Andrew F Olshan, Jane C Schroeder
1Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA. mfelini@hsc.unt.edu
Abstract:
X-ray cross complementing group 1 (XRCC1) and O6-methylguanine-DNA methyltransferase (MGMT) are pivotal repair genes focused on repairing lesions due to ionizing radiation, alkylating agents, and oxidative DNA damage, risk factors previously linked to gliomas. Using the population based San Francisco Adult Glioma study, we evaluated associations between XRCC1 Arg399Gln, MGMT Leu84Phe, and MGMT Ile143Val polymorphisms with glioma risk among white cases (n = 441 to 453) and controls (n = 487 to 526). We found no evidence of an association between XRCC1 genotypes and glioma. We observed a weak positive association for the MGMT Leu84Phe polymorphism (Leu or Phe/Phe versus Leu/Leu: adjusted OR = 1.26; CI 0.90-1.75) and the MGMT Ile143Val polymorphism (Ile or Val/Val versus Ile/Ile: adjusted OR = 1.20; CI 0.85-1.71).
Insights
This study found no link between XRCC1 gene variants and glioma risk. However, certain O6-methylguanine-DNA methyltransferase (MGMT) gene polymorphisms showed a weak positive association with glioma risk in adults.
Area of Science:
- Genetics
- Neuro-oncology
- Molecular Epidemiology
Background:
- DNA repair genes, including X-ray cross complementing group 1 (XRCC1) and O6-methylguanine-DNA methyltransferase (MGMT), are crucial for repairing DNA damage.
- Ionizing radiation, alkylating agents, and oxidative stress are risk factors for gliomas.
- Genetic variations in DNA repair genes may influence individual susceptibility to glioma.
Purpose of the Study:
- To investigate the association between specific polymorphisms in XRCC1 and MGMT genes and the risk of glioma.
- To explore the role of DNA repair gene variations in glioma development.
Main Methods:
- Population-based case-control study (San Francisco Adult Glioma study).
- Genotyping of XRCC1 Arg399Gln, MGMT Leu84Phe, and MGMT Ile143Val polymorphisms.
- Statistical analysis of associations between genotypes and glioma risk in white cases and controls.
Main Results:
- No significant association was found between XRCC1 genotypes and glioma risk.
- A weak positive association was observed for the MGMT Leu84Phe polymorphism (OR=1.26, CI 0.90-1.75).
- A weak positive association was also observed for the MGMT Ile143Val polymorphism (OR=1.20, CI 0.85-1.71).
Conclusions:
- XRCC1 polymorphisms do not appear to be associated with glioma risk.
- MGMT gene polymorphisms may play a minor role in glioma susceptibility.
- Further research is warranted to elucidate the role of MGMT in glioma development.
Related Concept Videos
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Base Excision Repair
The first step of...
Long-patch Base Excision Repair